Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z5FC
|
|||
| Former ID |
DIB011074
|
|||
| Drug Name |
Allogeneic cytotoxic T-cell therapy
|
|||
| Synonyms |
Allogeneic cytotoxic T-cell therapy (EBV-related post-transplantation lymphoproliferative disease)
Click to Show/Hide
|
|||
| Indication | Epstein barr virus infection [ICD-11: 1C80; ICD-9: 75] | Phase 2 | [1] | |
| Company |
University of Edinburgh
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 2007 Aug 15;110(4):1123-31. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.